0000899243-21-006912.txt : 20210217 0000899243-21-006912.hdr.sgml : 20210217 20210217170106 ACCESSION NUMBER: 0000899243-21-006912 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210215 FILED AS OF DATE: 20210217 DATE AS OF CHANGE: 20210217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waltzman Roger J. CENTRAL INDEX KEY: 0001678987 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32979 FILM NUMBER: 21645805 MAIL ADDRESS: STREET 1: C/O JAGUAR ANIMAL HEALTH, INC. STREET 2: 201 MISSION STREET, SUITE 2375 CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Molecular Templates, Inc. CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-15 0 0001183765 Molecular Templates, Inc. MTEM 0001678987 Waltzman Roger J. C/O MOLECULAR TEMPLATES, INC. 9301 AMBERGLEN BLVD., SUITE 100 AUSTIN TX 78729 0 1 0 0 See remarks Stock Option (right to buy) 14.05 2021-02-15 4 A 0 125000 0.00 A 2031-02-15 Common Stock 125000 125000 D 25% of the shares subject to the option shall vest on February 15, 2022, and thereafter, the remaining 75% of the shares subject to the option shall vest pro rata on a monthly basis over the following 36 months. Chief Medical Officer /s/ Roger J. Waltzman 2021-02-17